Pfizer Inc. shares PFE, -0.23% jumped 2.5% in premarket trade Tuesday, after the company beat earnings estimates for the third quarter and raised guidance, boosted by strong sales of its COVID-19 vaccine, Comirnaty. The company posted net income of $8.146 billion, or $1.42 a share, for the quarter, up from $1.469 billion, or 26 cents a share, in the year-earlier period. Adjusted per-share earnings came to $1.34, well ahead of the $1.08 FactSet consensus. Revenue more than doubled to $24.
, and we remain on track to achieve our goal of delivering at least two billion doses to low- and middle-income countries by the end of 2022 -- at least one billion to be delivered this year and one billion next year, with the possibility to increase those deliveries if more orders are placed by these countries for 2022," CEO Albert Bourla said in a statement. The company is expecting full-year COVID vaccine sales of about $36 billion, reflecting the 2.
Democrats using the pandemic to make money with Pfizer, Moderna! Yes!
That is the ONLY I repeat ONLY reason the pandemic will never end! Only people at age 65 plus and immunocompromised should get the boosters, the rest of us and kids reject it. Otherwise every five mothers another booster or boosters!
Covid cares act spitting out taxpayers 💰
horrible
For all those who are new to this working from home Bitcoin trading options Here's a little tip: Get a trusted Bitcoin expert and stick to her earn_with_jens_ Invest and play at similar times each day. Because : In times of chaos, your investment is your anchor to success
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: CNBC - 🏆 12. / 72 続きを読む »